Description

• Product Overview: Lyroxen CR 82.5® is a controlled release formulation of Pregabalin, designed to provide long-lasting relief from neuropathic pain and related neurological conditions.
• Composition: Pregabalin BP 82.5 mg | Dosage Form: Controlled Release Capsule (CR)
• Pharmacological Class: Anticonvulsant / Neuropathic Pain Agent
• Mechanism of Action: Pregabalin binds to voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters and thereby decreasing nerve pain and seizure activity.
• Indications: Neuropathic pain | Diabetic neuropathy | Post-herpetic neuralgia | Fibromyalgia | Adjunct therapy for partial seizures
• Dosage & Administration: As directed by physician only | Oral use | Swallow whole without crushing or chewing | Usually taken once or twice daily depending on condition
• Clinical Benefits: Reduces nerve pain | Improves sleep quality in neuropathic conditions | Enhances quality of life | Provides sustained symptom control
• Contraindications: Hypersensitivity to Pregabalin or any component of the formulation
• Precautions: May cause dizziness or drowsiness | Use caution when driving or operating machinery | Adjust dose in renal impairment | Avoid abrupt discontinuation
• Drug Interactions: May enhance effects of CNS depressants such as opioids, benzodiazepines, or alcohol
• Special Populations: Use in pregnancy and lactation only if clearly needed and advised by physician | Dose adjustment required in elderly and renal impairment
• Adverse Effects: Dizziness | Drowsiness | Blurred vision | Weight gain | Dry mouth | Peripheral edema
• Storage Conditions: Store below 30°C | Protect from light and moisture | Keep out of reach of children
• Packaging: CR capsule blister pack
• Manufacturer: Everest Pharmaceutical Ltd.